These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2403532)

  • 21. Characterization of rcsB and rcsC from Escherichia coli O9:K30:H12 and examination of the role of the rcs regulatory system in expression of group I capsular polysaccharides.
    Jayaratne P; Keenleyside WJ; MacLachlan PR; Dodgson C; Whitfield C
    J Bacteriol; 1993 Sep; 175(17):5384-94. PubMed ID: 8366025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An extraintestinal, pathogenic isolate of Escherichia coli (O4/K54/H5) can produce a group 1 capsule which is divergently regulated from its constitutively produced group 2, K54 capsular polysaccharide.
    Russo TA; Singh G
    J Bacteriol; 1993 Dec; 175(23):7617-23. PubMed ID: 8244930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
    Coughlin RT; Bogard WC
    J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.
    Benedí VJ; Ciurana B; Tomás JM
    J Clin Microbiol; 1989 Jan; 27(1):82-7. PubMed ID: 2643625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
    Allen PM; Fisher D; Saunders JR; Hart CA
    J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of K-1 capsule, smooth lipopolysaccharides, traT gene, and Colicin V production with complement resistance and virulence of avian Escherichia coli.
    Wooley RE; Nolan LK; Brown J; Gibbs PS; Giddings CW; Turner KS
    Avian Dis; 1993; 37(4):1092-6. PubMed ID: 8141739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P1 bacteriophage and tellurite sensitivity in Klebsiella pneumoniae and Escherichia coli.
    Tomás J; Regué M; Parés R; Jofre J; Kay WW
    Can J Microbiol; 1984 Jun; 30(6):830-6. PubMed ID: 6386131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of the K30 (group I) capsule in Escherichia coli O9:K30 does not require attachment to lipopolysaccharide lipid A-core.
    MacLachlan PR; Keenleyside WJ; Dodgson C; Whitfield C
    J Bacteriol; 1993 Dec; 175(23):7515-22. PubMed ID: 8244920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the SDS-PAGE patterns of outer membrane proteins from Escherichia coli strains that have lost the ability to form K1 antigen and varied in the susceptibility to normal human serum.
    Cisowska A; Bugla-Płoskońska G
    Folia Microbiol (Praha); 2014 Jan; 59(1):37-43. PubMed ID: 23794053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of beta-lactam antibiotics on serum resistance of K1-positive blood culture isolates of Escherichia coli.
    Suerbaum S; Leying H; Meyer B; Opferkuch W
    Antimicrob Agents Chemother; 1990 Apr; 34(4):628-31. PubMed ID: 2188587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
    Bortolussi R; Ferrieri P; Björkstén B; Quie PG
    Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies against the capsular K antigen of Escherichia coli (O9:K30(A):H12): characterisation and use in analysis of K antigen organisation on the cell surface.
    Homonylo MK; Wilmot SJ; Lam JS; MacDonald LA; Whitfield C
    Can J Microbiol; 1988 Oct; 34(10):1159-65. PubMed ID: 2461792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relatedness of O-specific lipopolysaccharide side chain genes from strains of Shigella boydii type 12 belonging to two clonal groups and from Escherichia coli O7:K1.
    Valvano MA; Marolda CL
    Infect Immun; 1991 Nov; 59(11):3917-23. PubMed ID: 1718868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J; Beckerdite-Quagliata S; Elsbach P
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
    Hancock RE; Mutharia LM; Chan L; Darveau RP; Speert DP; Pier GB
    Infect Immun; 1983 Oct; 42(1):170-7. PubMed ID: 6413410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of the rol gene encoding the regulator of lipopolysaccharide O-chain length in Escherichia coli and its influence on the expression of group I capsular K antigens.
    Dodgson C; Amor P; Whitfield C
    J Bacteriol; 1996 Apr; 178(7):1895-902. PubMed ID: 8606162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutants of Escherichia coli O9:K30 with altered synthesis and expression of the capsular K30 antigen.
    Whitfield C; Schoenhals G; Graham L
    J Gen Microbiol; 1989 Oct; 135(10):2589-99. PubMed ID: 2698913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.
    Burns SM; Hull SI
    Infect Immun; 1998 Sep; 66(9):4244-53. PubMed ID: 9712774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of phenotypic variants of Haemophilus influenzae type b to serum bactericidal activity: relation to surface lipopolysaccharide.
    Gilsdorf JR; Ferrieri P
    J Infect Dis; 1986 Feb; 153(2):223-31. PubMed ID: 3484771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.